Status of Anaplastic Lymphoma Kinase (ALK) in Malignant Mesothelioma

被引：0
|
作者：
Varesano, Serena [1 ]
Leo, Claudio [1 ]
Boccardo, Simona [1 ]
Salvi, Sandra [1 ]
Truini, Mauro [1 ]
Ferro, Paola [3 ]
Fedeli, Franco [3 ]
Canessa, Pier Aldo [4 ]
Dessanti, Paolo [3 ]
Pistillo, Maria Pia [2 ]
Roncella, Silvio [3 ]
机构：
[1] Natl Inst Canc Res, Div Histopathol & Cytopathol, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[2] Natl Inst Canc Res, Unit Tumor Epigenet, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[3] Azienda Sanit Locale 5, Div Histopathol & Cytopathol, La Spezia, Italy
[4] Azienda Sanit Locale 5, Div Pneumol, La Spezia, Italy
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 05期
关键词：
Anaplastic lymphoma kinase; crizotinib; fluorescent in situ hybridization; immunohistochemistry; malignant mesothelioma; targeted therapy; CELL LUNG-CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Malignant mesothelioma (MM) is a particularly aggressive type of primary tumor, associated with exposure to asbestos, and characterized by high mortality. To date, there is no curative therapy for MM. The receptor anaplastic lymphoma kinase (ALK) was found to be mutated in many cases of cancer and used as a target in biological therapies. We investigated whether this pharmacological treatment could also be applicable to MM. Materials and Methods: The state of ALK was analyzed by immunohistochemistry and fluorescent in situ hybridization in 63 MM tissue specimens. Results: None of the 63 MM samples showed overexpression or translocation of ALK. Conclusion: Our preliminary data exclude the utility of analysis of the ALK gene in MM and suggest that ALK inhibitor therapy is not applicable to MM.
引用
收藏
页码：2589 / 2592
页数：4
相关论文
共 50 条
  • [1] Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum
    Loharamtaweethong, Kongsak
    Puripat, Napaporn
    Aoonjai, Nadda
    Sutepvarnon, Apisada
    Bandidwattanawong, Chanyoot
    HISTOPATHOLOGY, 2016, 68 (04) : 603 - 607
  • [2] Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Children and Young Adults with Mesothelioma
    Mian, I.
    Abdullaev, Z.
    Morrow, B.
    Gao, S.
    Mettienen, M.
    Wei, J.
    Khan, J.
    Pack, S.
    Hassan, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1145 - S1145
  • [3] Nucleophosmin (NPM) anaplastic lymphoma kinase(ALK) fusion transcript in malignant lymphoma.
    Kaneita, Y
    Uchida, T
    Irie, T
    Yasukawa, K
    Hanai, M
    Kura, Y
    Yamazaki, T
    Sawada, U
    Horie, T
    BLOOD, 1996, 88 (10) : 3465 - 3465
  • [4] STATUS OF ANAPLASTIC LYMPHOMA KINASE (ALK) GENE IN INFLAMMATORY BREAST CARCINOMA
    Krishnamurthy, S.
    Woodward, W.
    Reuben, J. M.
    Tepperberg, J.
    Ogura, D.
    Niwa, S.
    Ueno, N. T.
    CANCER RESEARCH, 2012, 72
  • [5] Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
    Krishnamurthy, Savitri
    Woodward, Wendy
    Yang, Wei
    Reuben, James M.
    Tepperberg, James
    Ogura, Dai
    Niwa, Shin-ichiro
    Huo, Lei
    Gong, Yun
    El-Zein, Randa
    Gonzalez-Angulo, Ana M.
    Mac Gregor, Mariana Chavez
    Alvarez, Ricardo
    Lucci, Anthony
    Valero, Vicente
    Ueno, Naoto T.
    SPRINGERPLUS, 2013, 2 : 1 - 7
  • [6] Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma.
    van Gaal, J. C.
    Flucke, U. E.
    Roeffen, M. H. S.
    de Bont, E. S.
    Suurmeijer, A. J.
    van der Graaf, W. T.
    Versleijen-Jonkers, Y. M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Implications of ALK (anaplastic lymphoma kinase) in oncohematology
    Cluzeau, T.
    Pecuchet, N.
    Mounier, N.
    Vignot, S.
    BULLETIN DU CANCER, 2010, 97 (08) : 991 - 996
  • [8] Translocations involving anaplastic lymphoma kinase (ALK)
    Duyster, J
    Bai, RY
    Morris, SW
    ONCOGENE, 2001, 20 (40) : 5623 - 5637
  • [9] Translocations involving anaplastic lymphoma kinase (ALK)
    Justus Duyster
    Ren-Yuan Bai
    Stephan W Morris
    Oncogene, 2001, 20 : 5623 - 5637
  • [10] Analysis of factors involved in malignant progression of anaplastic large cell lymphoma kinase (ALK) - Negative anaplastic large cell lymphoma
    Nakamaki, T
    Maeda, T
    Nakashima, H
    Hattori, M
    Usui, T
    Tomoyasu, S
    Honma, Y
    BLOOD, 2004, 104 (11) : 894A - 894A
12345